PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of cddisLink to Publisher's site
 
Cell Death Dis. 2017 March; 8(3): e2698.
Published online 2017 March 23. doi:  10.1038/cddis.2017.96
PMCID: PMC5386586

Other bricks for the correct construction of the mitochondrial permeability transition pore complex

In recent years, the concept of the mitochondrial permeability transition pore (mPTP) has attracted considerable attention from researchers in the field of pathophysiology, focusing on mitochondrial function as a potential therapeutic target. Indeed, given that the mPTP is considered to be the main and final effector of cell death in various disorders,1, 2 numerous and progressive efforts have been undertaken using this novel molecular target, both in clinical trials3, 4 and especially in basic research. Although the exact structure of this supramolecular entity is largely unknown, studies beginning in 2013 have begun to elucidate the structure of the pore-forming component – the C subunit of the F1/FO ATP synthase.5, 6, 7, 8

In 2013, two independent groups described that the potential role of the C subunit in pore opening depends on its expression levels7 and its phosphorylation status.6 Then, Alavian et al.5 demonstrated that the purified C subunit, when reconstituted into liposomes forms a voltage-sensitive channel, leading to the rapid and uncontrolled loss of the membrane permeability transition (MPT).

These studies contributed to the hypothesis that F1/FO ATP synthase C subunit (possibly in its c-ring form) generates a nonspecific pore on the inner mitochondrial membrane that is responsible for the permeability transition under precise conditions. Nonetheless, such a hypothesis lacks a mechanistic explanation as to how a high-stability, lipid-filled c-ring could exit the dimeric F1/FO ATP synthase complex and undergo a marked rearrangement that would allow for channel formation.9

A recent article from Pavlov et al. published in Cell Death Discovery provides a new insight into this, as yet poorly understood mechanism of mPTP formation. In this work, Elustondo et al.10 provide an elegant confirmation of previous reports and better define the mechanism of action of this crucial MPT event. In their study, they utilized sophisticated biochemical methods and a standardized in vivo approach to provide a strong link between calcium-induced mPTP, de novo assembly of the channel comprising the C subunit, and tissue damage in a model of ischemia–reperfusion injury in the brain.10 These authors advanced the possibility that mPTP channel assembly might be stimulated by a mitochondrial calcium trigger signal, similar to mPTP channel opening as described in their previous studies.11

First, they show that a certain amount of C subunit could be chloroform-extracted from mitochondria with induced MPT, whereas a negligible amount was obtained when the mPTP was not stimulated or inhibited. This event was independent of its expression levels, suggesting that the C subunit changes its interaction with dimeric F1/FO ATP synthase, resulting in MPT.10

In a previous publication, the same group reported that a voltage-dependent channel, including polyhydroxybutyrate (PHB) and inorganic polyphosphate (polyP), could be isolated by chloroform extraction from mitochondria. It has already been reported that polyP is required for mPTP opening in different cell lines12 and that PHB localizes to mitochondria where it induces PTP.13 Indeed, in this paper, they were able to reaffirm that PHB and polyP were collected from mitochondria with a calcium-triggered mPTP, and that their levels correlated with C subunit levels.

It is widely recognized that the mPTP molecular pathway is deeply involved in ischemia–reperfusion injuries, such as myocardial infarction,8, 14, 15 stroke, and liver and kidney transplantation. By studying a model of in vivo mPTP-dependent stroke damage, the authors demonstrate high C subunit accumulation in the injured hemisphere, as compared with control hemisphere, convincingly substantiating the function and requirement of the C subunit/polyP/PHB triad in a translational context.

As proposed by the authors, during Ca2+-induced MPT, the C subunit associates with polyP and PHB, promoting the generation of a water-permeable channel.10 Given that the C subunit is a hydrophobic protein with properties very similar to those of lipids, it is not expected to be able to form water-filled pores in its c-ring form (Figure 1). These data suggest that the C subunit is responsible for forming the calcium-dependent channel with the help of polyP possibly serving as the hydrophilic coating of the pore.

Figure 1
Hypothetical structure of the central conducting pore part. A portion of the mitochondrial structure is represented. In healthy cells (on the left), C subunit is part of the dimeric F1/FO ATP synthase and contributes to ATP production (in blue – ...

Mechanistically, this work leaves questions regarding how the C subunit exits the ATP synthase complex: are some major rearrangements required? Is the process catalyzed by other known mPTP components or by polyP or PHB themselves? Nonetheless, these study takes great strides toward a more complete understanding of MPT. Alongside parallel discoveries of other new and important modulators, this work further supports the C subunit-centric vision of mPTP. We are confident that further studies will begin to explore and describe the use of this target in counteracting ischemia–reperfusion injury-based diseases.

Acknowledgments

PP is grateful to Camilla degli Scrovegni for providing continuous support. PP is supported by Telethon (GGP15219/B), the Italian Association for Cancer Research (AIRC) (IG-18624), the Italian Cystic Fibrosis Research Foundation (19/2014), the Italian Ministry of Education, University and Research (COFIN no. 20129JLHSY_002, FIRB no. RBAP11FXBC_002, and Futuro in Ricerca no. RBFR10EGVP_001), local funds from the University of Ferrara, and the Italian Ministry of Health. CG is supported by AIRC (MFAG-13521), the Italian Ministry of Health, Cariplo and local funds from the University of Ferrara.

Footnotes

The authors declare no conflict of interest.

References

  • Bonora M et al Oncogene 2015; 34: 1475–1486. [PubMed]
  • Galluzzi L et al Cell Death Differ 2015; 22: 58–73. [PMC free article] [PubMed]
  • Ottani F et al J Am Coll Cardiol 2016; 67: 365–374. [PubMed]
  • Piot C et al N Engl J Med 2008; 359: 473–481. [PubMed]
  • Alavian KN et al Proc Natl Acad Sci USA 2014; 111: 10580–10585. [PubMed]
  • Azarashvili T et al Cell Calcium 2014; 55: 69–77. [PubMed]
  • Bonora M et al Cell Cycle 2013; 12: 674–683. [PMC free article] [PubMed]
  • Campo G et al Int J Cardiol 2016; 221: 993–997. [PubMed]
  • Halestrap AP Front Oncol 2014; 4: 234. [PMC free article] [PubMed]
  • Elustondo PA et al Cell Death Discov 2016; 2: 16070. [PMC free article] [PubMed]
  • Pavlov E et al Biophys J 2005; 88: 2614–2625. [PubMed]
  • Seidlmayer LK et al J Gen Physiol 2012; 139: 321–331. [PMC free article] [PubMed]
  • Elustondo PA et al PLoS ONE 2013; 8: e75812. [PMC free article] [PubMed]
  • Halestrap AP et al J Mol Cell Cardiol 2015; 78: 129–141. [PubMed]
  • Morciano G et al J Mol Cell Cardiol 2015; 78: 142–153. [PubMed]

Articles from Cell Death & Disease are provided here courtesy of Nature Publishing Group